User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 13:42, 17 September 2015 (diff | hist) . . (-189) . . Part:BBa K1607011
- 13:40, 17 September 2015 (diff | hist) . . (0) . . N File:LCR protocols.pdf (current)
- 13:40, 17 September 2015 (diff | hist) . . (+4) . . See oligos and protocols (→SCFV LCR PROTOCOLS) (current)
- 13:38, 17 September 2015 (diff | hist) . . (-27) . . See oligos and protocols (→SCFV LCR PROTOCOLS)
- 13:37, 17 September 2015 (diff | hist) . . (-6) . . See oligos and protocols (→SCFV LCR PROTOCOLS)
- 13:36, 17 September 2015 (diff | hist) . . (+58) . . See oligos and protocols (→SCFV LCR PROTOCOLS)
- 13:19, 17 September 2015 (diff | hist) . . (+6) . . Part:BBa K1607011:Design (→Source)
- 13:19, 17 September 2015 (diff | hist) . . (+8) . . Part:BBa K1607011:Design (→Source)
- 13:16, 17 September 2015 (diff | hist) . . (+675) . . Part:BBa K1607011:Design
- 13:08, 17 September 2015 (diff | hist) . . (+1,368) . . N Part:BBa K1607011 (Created page with "===Part Description=== ---- The anti-p185her2/neu antibody chA21 mediates specific inhibitory effects on p185her2/neu-overexpressed cancer cells, as well as human breast and ova...")
- 09:53, 16 September 2015 (diff | hist) . . (-10) . . Part:BBa I13001 (→Experience)
- 09:52, 16 September 2015 (diff | hist) . . (+8) . . Part:BBa I13001 (→Experience)
- 09:51, 16 September 2015 (diff | hist) . . (-3) . . Part:BBa I13001 (→Experience)
- 09:46, 16 September 2015 (diff | hist) . . (+302) . . Part:BBa I13001 (→Experience)
- 09:35, 16 September 2015 (diff | hist) . . (0) . . N File:QQ图片20150210175655.jpg (current)
- 09:34, 16 September 2015 (diff | hist) . . (0) . . N File:QQ图片20150210175650.jpg (current)
- 06:45, 24 August 2015 (diff | hist) . . (-33) . . Part:BBa K1607010 (→The obtainment of DNA sequence)
- 06:43, 24 August 2015 (diff | hist) . . (-1) . . Part:BBa K1607010 (→The obtainment of DNA sequence)
- 06:42, 24 August 2015 (diff | hist) . . (+10) . . Part:BBa K1607010 (→The obtainment of DNA sequence)
- 06:39, 24 August 2015 (diff | hist) . . (-5) . . Part:BBa K1607010 (→The obtainment of DNA sequence)
- 06:37, 24 August 2015 (diff | hist) . . (0) . . N File:LCR assembly result.tif (current)
- 06:11, 24 August 2015 (diff | hist) . . (+42) . . Part:BBa K1607010 (→The obtainment of DNA sequence)
- 06:09, 24 August 2015 (diff | hist) . . (-27) . . Part:BBa K1607010 (→The obtainment of DNA sequence)
- 06:04, 24 August 2015 (diff | hist) . . (+1) . . See oligos and protocols (→SCFV LCR PROTOCOL)
- 06:02, 24 August 2015 (diff | hist) . . (+5) . . Part:BBa K1607010:Design (→Source) (current)
- 06:02, 24 August 2015 (diff | hist) . . (-5) . . Part:BBa K1607010:Design (→Source)
- 06:01, 24 August 2015 (diff | hist) . . (+1,598) . . N See oligos and protocols (Created page with "===SCFV LCR OLIGOS=== AATTCCGattgtgtcc ggacacaatCGGAATTCATGGGTTCTACTCAAG CATATCAGTACCAGTACAAACTTGAGTAGAACCCATG TTTGTACTGGTACTGATATGAAGTTGAGA...")
- 06:00, 24 August 2015 (diff | hist) . . (+14) . . Part:BBa K1607010:Design (→Source)
- 05:55, 24 August 2015 (diff | hist) . . (-6) . . Part:BBa K1607010:Design (→Source)
- 05:53, 24 August 2015 (diff | hist) . . (-13) . . Part:BBa K1607010:Design (→Source)
- 05:53, 24 August 2015 (diff | hist) . . (-1,547) . . Part:BBa K1607010:Design (→Source)
- 05:50, 24 August 2015 (diff | hist) . . (+30) . . Part:BBa K1607010:Design (→Source)
- 05:46, 24 August 2015 (diff | hist) . . (+43) . . Part:BBa K1607010 (→The obtainment of DNA sequence)
- 05:44, 24 August 2015 (diff | hist) . . (+12) . . Part:BBa K1607010 (→The obtainment of DNA sequence)
- 05:41, 24 August 2015 (diff | hist) . . (+1) . . Part:BBa K1607010:Design (→Design note)
- 05:39, 24 August 2015 (diff | hist) . . (+24) . . Part:BBa K1607010:Design
- 05:34, 24 August 2015 (diff | hist) . . (-120) . . Part:BBa K1607010:Design (→Source)
- 05:31, 24 August 2015 (diff | hist) . . (+1,906) . . m Part:BBa K1607010:Design (→Source)
- 05:22, 24 August 2015 (diff | hist) . . (+7) . . m Part:BBa K1607010 (→The obtainment of DNA sequence)
- 05:21, 24 August 2015 (diff | hist) . . (+7) . . m Part:BBa K1607010 (→Part Description)
- 05:21, 24 August 2015 (diff | hist) . . (-7) . . m Part:BBa K1607010 (→The obtainment of DNA sequence)
- 05:20, 24 August 2015 (diff | hist) . . (+2) . . m Part:BBa K1607010 (→Part Description)
- 05:20, 24 August 2015 (diff | hist) . . (-4) . . m Part:BBa K1607010 (→Part Description)
- 05:19, 24 August 2015 (diff | hist) . . (+1,486) . . Nm Part:BBa K1607010 (Created page with "===Part Description=== The anti-p185her2/neu antibody chA21 mediates specific inhibitory effects on p185her2/neu-overexpressed cancer cells, as well as human breast and ovari...")
- 05:13, 24 August 2015 (diff | hist) . . (+223) . . m Part:BBa K1607010:Design (→References)
- 05:11, 24 August 2015 (diff | hist) . . (+1) . . m Part:BBa K1607010:Design (→Source)
- 05:11, 24 August 2015 (diff | hist) . . (-331) . . m Part:BBa K1607010:Design (→Source)
- 05:05, 24 August 2015 (diff | hist) . . (-379) . . Part:BBa K1607010:Design (→Design Notes)
- 04:54, 24 August 2015 (diff | hist) . . (-2) . . Part:BBa K1607010:Design (→Design Notes)
- 04:27, 6 August 2015 (diff | hist) . . (-1) . . Part:BBa K1607000:Design (→Design Notes) (current)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)